Skip to main content
. 2020 Aug 31;18(3):402–411. doi: 10.9758/cpn.2020.18.3.402

Table 1.

Characteristics of participants with or without stimulant medication

Variables Total patients (n = 97) On stimulants (n = 28) No stimulant medication (n = 69) pvalue
Age 6.1 ± 0.3 6.1 ± 1.9 6.0 ± 1.7 0.91
Sex, male/female 78 (80.4)/19 (19.6) 24 (85.7)/4 (14.3) 54 (78.3)/15 (21.7) 0.40
Race/ethnicity, white/non-white 62 (63.9)/35 (36.1) 21 (75.0)/7 (25.0) 41 (59.4)/28 (40.6) 0.79
Treatment duration 161.9 ± 106.2 161.1 ± 113.5 163.8 ± 87.3 0.91
Clinical diagnoses
ADHD 45 (46.4) 21 (75.0) 24 (34.8)
ODD 51 (52.6) 13 (46.4) 38 (55.1)
CD 2 (2.0) 1 (3.6) 1 (1.4)
DBD not otherwise specified 28 (28.9) 6 (21.4) 22 (31.9)
DMDD 3 (3.1) 0 (0) 3 (4.3)
Reactive Attachment Disorder 10 (10.3) 2 (7.1) 8 (11.6)
Generalized Anxiety Disorder 4 (4.1) 1 (3.6) 3 (4.3)
Bipolar Disorder 1 (1.0) 0 (0) 1 (1.4)
Adjustment Disorder 7 (7.2) 1 (3.6) 6 (8.7)
PTSD 8 (8.2) 4 (14.3) 4 (5.8)
CBCL score profiles
Attentional problems 65.9 ± 9.2 65.4 ± 9.40 67.0 ± 8.9 0.45
Aggressive behavior 74.4 ± 13.2 74.6 ± 13.9 73.9 ± 11.5 0.82
Externalizing problems 71.1 ± 10.5 71.2 ± 11.1 71.0 ± 9.1 0.94
ADHD-DSM 65.5 ± 9.0 65.2 ± 9.2 66.3 ± 8.5 0.59
ODD-DSM 70.6 ± 8.4 70.9 ± 8.8 69.9 ± 7.5 0.58
Irritability 4.5 ± 1.6 4.6 ± 1.5 4.2 ± 1.8 0.24
CD-DSM 73.9 ± 9.4 (n = 51) 71.2 ± 9.2 (n = 19) 75.6 ± 9.3 (n = 32) 0.11

Values are presented as mean ± standard deviation or number (%).

ADHD, Attention-Deficit/Hyperactivity Disorder; ODD, Oppositional Defiant Disorder; CD, Conduct Disorder; DBD, Disruptive Behavior Disorder; DMDD, Disruptive Mood Dysregulation Disorder; PTSD, Post-Traumatic

Stress Disorder; DSM, Diagnostic and Statistical Manual of Mental Disorders.